COVID-19 vaccination in Nigeria

Last updated

COVID-19 vaccination in Nigeria
COVID-19 Doses in Nigeria map.svg
Date5 March 2021-present
Location Nigeria
Cause COVID-19 pandemic
Organised byNational Primary Health Care Development Agency
Participants
  • 6,021,560 first doses [1]
  • 3,369,628 second doses [1]
  • 9,391,188 total doses [1]
Outcome2.81% of the Nigerian population received at least one dose [2]
Website nphcda.gov.ng

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 19 November 2021, 6,021,560 people have received their first dose a COVID-19 vaccine, and 3,369,628 people have received their second dose. [1]

Contents

History

Timeline

March 2021

On 2 March, the first shipment of four million Oxford–AstraZeneca COVID-19 vaccine doses from the COVAX initiative arrived at Nnamdi Azikiwe International Airport. [3]

Cyprian Ngong, a doctor at National Hospital, Abuja, became the first person in Nigeria to receive a COVID-19 vaccine on 5 March. [4] [5]

President Muhammadu Buhari received his first COVID-19 vaccine dose on 6 March. [6]

On 21 March, Nigeria received an additional 300,000 doses of Oxford–AstraZeneca COVID-19 vaccines from MTN. [7]

By the end of March, 0.7 million vaccine doses had been administered.

April 2021

On 6 April, Nigeria received 100,000 doses of Oxford–AstraZeneca COVID-19 vaccines from the Government of India. [8]

By the end of April, 1.2 million vaccine doses had been administered.

May 2021

By the end of May, 1.6 million vaccine doses had been administered.

June 2021

By the end of June, 3.4 million vaccine doses had been administered.

July 2021

The vaccination campaign in Nigeria was paused on 9 July due to exhaustion of the first COVAX shipment that arrived in March. [9] [10]

By the end of July, 3.9 million vaccine doses had been administered.

August 2021

On 1 August, Nigeria received four million doses of Moderna COVID-19 vaccines from the United States. [11]

The second phase of the vaccination rollout began on 16 August. [12]

By the end of August, 4.2 million vaccine doses had been administered.

September 2021

By the end of September, 6.9 million vaccine doses had been administered.

October 2021

On 8 October, Nigeria received 500,000 doses of Oxford–AstraZeneca COVID-19 vaccines from the Government of France. [13]

By the end of October, 8.6 million vaccine doses had been administered. 4% of the target population had been fully vaccinated by the end of the month.

Vaccines on order

VaccineApprovalDeployment
Oxford–AstraZeneca Green check.svg YesGreen check.svg Yes
Moderna Green check.svg YesGreen check.svg Yes
Janssen Green check.svg YesDark Red x.svg No
Sputnik V Green check.svg YesDark Red x.svg No
Pfizer–BioNTech Green check.svg YesDark Red x.svg No
Sinopharm BIBP Green check.svg YesDark Red x.svg No

Rollout schedule

COVID-19 vaccination plan in Nigeria [14] [12]
PhasePriority groupProgress
1Health workers and supporting staff, frontline workers and first respondersIn progress
2Priority 1: Persons aged 60 years and above.
Priority 2: Persons aged 50-59 years
3Persons aged 18-49 years with co-morbidities
4The rest of the eligible population aged 18-49 years

Statistics

Total number of people receiving vaccinations in Nigeria as of 19 November 2021

  Unvaccinated population: ~202,009,520 people (97.15%)
  Population who received 1st dose: 2,651,932 people (19 November 2021) (1.26%)
  Population who are fully vaccinated: 3,369,628 people (19 November 2021) (1.59%)

By state

Proportion vaccinated (1st dose) [lower-alpha 1]

5.4%

Proportion vaccinated (2nd dose) [lower-alpha 2]

3.0%
COVID-19 vaccination in Nigeria by state, as of 19 November 2021 [1]
StateTotal clients vaccinated (1st dose)Total clients vaccinated (2nd dose)Total Doses
Abia 76,37546,108122,483
Adamawa 90,72769,408160,135
Akwa Ibom 89,50253,675143,177
Anambra 74,21139,464113,675
Bauchi 153,08169,521222,602
Bayelsa 39,58816,81556,403
Benue 176,16565,547241,712
Borno 86,04148,373134,414
Cross River 130,22876,869207,097
Delta 139,86381,908221,771
Ebonyi 64,41931,10695,525
Edo 149,16371,976221,139
Ekiti 177,82489,145266,969
Enugu 82,89844,118127,016
FCT 272,001166,031438,032
Gombe 104,52867,335171,863
Imo 85,65246,383132,035
Jigawa 117,10352,403169,506
Kaduna 211,129132,166343,295
Kano 226,744142,549369,293
Katsina 146,06169,582215,643
Kebbi 92,84562,418155,263
Kogi 77,03038,690115,720
Kwara 201,156100,537301,693
Lagos 1,009,315649,2561,658,571
Nasarawa 115,03979,080194,119
Niger 161,26672,928234,194
Ogun 314,371153,834468,205
Ondo 252,607115,396368,003
Osun 203,04493,031296,075
Oyo 298,217153,510451,727
Plateau 127,17379,500206,673
Rivers 193,123100,949294,072
Sokoto 55,97940,22396,202
Taraba 74,53143,391117,922
Yobe 61,64440,920102,564
Zamfara 90,91765,483156,400

See also

Notes

  1. Percentage of target reached = Total clients vaccinated (1st dose)/Total eligible population targeted for COVID-19 vaccination × 100%.
  2. Percentage of target reached = Total clients vaccinated (2nd dose)/Total eligible population targeted for COVID-19 vaccination × 100%.

Related Research Articles

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). It is one of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well logistics, country readiness and in-country delivery.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Australia Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Cape Verde has begun vaccinations against COVID-19.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Ghana

COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.

COVID-19 vaccination in Bhutan

Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination campaign began in Fiji on the first quarter of 2021 and will continue throughout the year with the goal of vaccinating all eligible Fijians. The government has made it mandatory for all eligible adults to take the COVID-19 vaccines.

References

  1. 1 2 3 4 5 National Primary Health Care Development Agency (20 November 2021). "COVID-19 Vaccination Update: November 19th, 2021, in 36 States + the FCT. 6,021,560 of total eligible persons targeted for COVID-19 vaccination reached with first dose while 3,369,628 of total eligible persons targeted for COVID-19 vaccination reached with second dose (fully vaccinated). #YesToCOVID19Vaccine" . Retrieved 21 November 2021 via Facebook.
  2. Ritchie, Hannah; Ortiz-Ospina, Esteban; Beltekian, Diana; Mathieu, Edouard; Hasell, Joe; MacDonald, Bobbie; Giattino, Charlie; Appel, Cameron; Rodés-Guirao, Lucas; Roser, Max (5 March 2020). "Coronavirus (COVID-19) Vaccinations". Our World in Data. Retrieved 14 April 2021.
  3. "'Fantastic step forward': First COVAX vaccines arrive in Nigeria". Al Jazeera. 2 March 2021. Retrieved 14 March 2021.
  4. "AstraZeneca vaccine: Latest update about Nigeria vaccination programme and important tins to know". BBC News Pidgin. 4 March 2021. Retrieved 25 April 2021.
  5. @UNICEF_Nigeria (5 March 2021). "History is made! Dr. Cyprian Ngong, a Snr. Registrar at the National Hospital, Abuja is the first person to receive the #COVID19 vaccine in Nigeria. The vaccine was administered by @drfaisalshuaib, ED of @NphcdaNG during the flag-off of the #COVID19 vaccination drive in Abuja" (Tweet). Retrieved 25 April 2021 via Twitter.
  6. "President Buhari calls for Nigerians to follow his vaccine lead". Reuters. 7 March 2021. Retrieved 26 April 2021.
  7. Adebowale, Nike (22 March 2021). "Nigeria receives 300,000 doses of COVID-19 vaccines from MTN – Official". Premium Times . Retrieved 26 April 2021.
  8. Adebowale, Nike (6 April 2021). "Nigeria receives 100,000 doses of COVID-19 vaccine from India". Premium Times . Retrieved 26 April 2021.
  9. Adepoju, Paul (22 July 2021). "As Nigeria Runs Out of Vaccines, US Dose Donations Start to Arrive in Africa". Health Policy Watch. Retrieved 10 October 2021.
  10. "Nigeria to resume COVID vaccinations on Aug. 16". Reuters. 10 August 2021. Retrieved 10 October 2021.
  11. Rédaction Africanews (1 August 2021). "Nigeria receives four million Covid vaccine doses from the US". Africanews . Retrieved 10 October 2021.
  12. 1 2 Erunke, Joseph (16 August 2021). "COVID-19: FG flags off Phase 2 vaccination rollout". Vanguard . Abuja. Retrieved 10 October 2021.
  13. Adebowale, Nike (8 October 2021). "Nigeria receives 501,600 doses of AstraZeneca vaccines from France". Premium Times . Retrieved 10 October 2021.
  14. National Primary Health Care Development Agency [@NphcdaNG] (12 April 2021). "Here's Nigeria's #COVID19 Vaccination Plan. We are currently in Phase 1. Other Phases will be announced in due course. #YesToCOVID19Vaccine" (Tweet). Retrieved 30 April 2021 via Twitter.